← All grants

DoW Duchenne Muscular Dystrophy, Idea Development Award

Defense Health Agency Contracting Activity - DHACA · Opportunity HT942526DMDRPIDA

Deadline September 18, 2026 9 days left
Award range Not stated
Total program funding $2.5M

≈ 5 awards expected

PostedJune 17, 2026

Who can apply

About this opportunity

Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports impactful, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD) in the near term. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. The DMDRP strongly encourages research projects investigating therapies designed to demonstrate efficacy cross the life span, including infants, toddlers and nonambulatory individuals.Distinctive Features: The FY26 DMDRP IDA mechanism offers three eligibility career categories:• The Established Investigator category is for independent investigators at all academic levels, or equivalent• The New Investigator – Early-Stage category is for independent investigators early in their careers (i.e., within 10 years of their first faculty appointment or equivalent). Applicants in this category will be reviewed separately from Established Investigators.• The New Investigator – Transitioning category is for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy who are seeking to transition to a career in DMD, thereby bringing their expertise to the field. Applicants in this category will be reviewed separately from Established Investigators.Preliminary data relevant to DMD that supports the feasibility of the research hypotheses and research approaches are required for all applications. Clinical trials or clinical trial aims are not allowed.

Portfolio context — this listing covers more than this opportunity

This opportunity is funded under Assistance Listing 12.420 (“Military Medical Research and Development”), a broad federal program that made about 1078 new awards per year over the last five fiscal years (median award $846k). Those figures describe that whole portfolio — not this specific solicitation, so we don't show them as if they were this opportunity's track record.

Applicant counts per solicitation are not published by any federal agency — no one can honestly sell you that number. CDMRP publishes cumulative applications received and funded per program — source.

Apply on grants.gov →

Don't want to hunt for grants like this one? Get free deadline alerts for your state and focus areas.

Consultant or grant writer? See the client-ready Opportunity Brief for this grant — actual award sizes vs. the advertised ceiling, who wins, printable "prepared for your client" version.

Similar grants still open

OpportunityAgencyDeadlineAward ceilingEligible
A Science of Science Approach to Analyzing and Innovating the Biomedical Research Enterprise U.S. National Science Foundation September 9, 2026 0d left $250k Nonprofits
Public Wireless Supply Chain Innovation Fund Grant Program – Solutions for AI-Native RAN National Telecommunications and Information Admini September 9, 2026 0d left
Computer and Information Science and Engineering (CISE): Future Computing Research U.S. National Science Foundation September 10, 2026 1d left $12M
DoW Vision, Mentored Clinical Research Award Defense Health Agency Contracting Activity - DHACA September 10, 2026 1d left Nonprofits